Articles

The meeting of molecular biology and advanced artificial intelligence is marking a historic turning point for medicine. This is not simply about more powerful tools, but about a real paradigm shift: we are moving from a science that observes and describes life to one that can predict it — and increasingly, design it. For decades, biomedical research relied on a slow and costly trial-and-error approach. Developing a new drug could take more than ten years and cost over $2 bill

Despite decades of research, cancer remains one of the most complex challenges in modern medicine.The difficulty stems from its dynamic nature: it is not a single disease, but an evolutionary process fueled by profound transformations in cell behavior. Understanding these steps is essential to grasp why therapies targeting a single mechanism are often insufficient and why the most promising strategies today aim to hit multiple biological pathways simultaneously. The first fun

For decades, the concept of neurodiversity has been considered an exclusively human phenomenon. However, the frontiers of behavioral genomics and veterinary medicine reveal that conditions such as autism spectrum disorder (ASD) and ADHD have deep evolutionary roots, manifesting in analogous phenotypes in animals as well. These are not anomalies, but natural variants. The most tangible evidence of canine neurodiversity lies in DNA. Research conducted on Beagle populations has

Professor Antonio Giordano now contributes a dedicated column titled “Medicine – Highlights” to Il Mattino, one of Italy’s most esteemed and widely circulated daily newspapers, long-established as a cornerstone of Southern Italian journalism. This column will appear every Sunday in both print and digital formats. It serves as an insightful space for in-depth research with Professor Giordano, extending beyond the frontiers of medicine to the profound significance of human well